Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)Prognostic Study · 2020 · 337 citations
2Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysisMeta-Analysis · 2020 · 278 citations
3Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationshipsSystematic Review · 2020 · 1,217 citations
4Collider bias undermines our understanding of COVID-19 disease risk and severityOriginal Research · 2020 · 813 citations
5Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020Original Research · 2020 · 2,358 citations
6Failing Another National Stress Test on Health DisparitiesOriginal Research · 2020 · 160 citations
7Flexible regression models with cubic splinesPrognostic Study · 1989 · 2,722 citations
8Comparing smoothing techniques in Cox models for exposure–response relationshipsCohort Study · 2007 · 222 citations
9Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trialsThe Lancet Diabetes & Endocrinology · 2021
10Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialThe Lancet Diabetes & Endocrinology · 2021

More from The Lancet Diabetes & Endocrinology

More from University of Oxford